参考文献

本文中で引用した文献の一覧です。

ノート出典の確認方法
  • 英語の論文はすべて PubMed で書誌情報(著者・雑誌・巻・号・ページ・DOI・PMID)を照合 し、本文で使った主張・数値は 各論文の抄録 (abstract) で確認 しました。抄録のない文献(総説・コンセンサス声明など)は、タイトルと書誌情報の範囲で、論点を確認できるものに限って引用しています。
  • 教科書 (Pawlina と Ross 2020年) は、組織像の一般的な記載の出典として挙げています。
  • 本文の細部まで確認できていない文献もあります。講義や論文で引用する場合は、必ず原典(DOI のリンク先)を確認してください。
Arita, Y., S. Kihara, N. Ouchi, et al. 1999. “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.” Biochemical and Biophysical Research Communications 257 (1): 79–83. https://doi.org/10.1006/bbrc.1999.0255.
Arner, E., P. O. Westermark, K. L. Spalding, et al. 2010. “Adipocyte turnover: relevance to human adipose tissue morphology.” Diabetes 59 (1): 105–9. https://doi.org/10.2337/db09-0942.
Arner, P. 2005. “Human fat cell lipolysis: biochemistry, regulation and clinical role.” Best Practice & Research. Clinical Endocrinology & Metabolism 19 (4): 471–82. https://doi.org/10.1016/j.beem.2005.07.004.
Björntorp, P. 1990. “"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.” Arteriosclerosis (Dallas, Tex.) 10 (4): 493–96.
Bujalska, I. J., S. Kumar, and P. M. Stewart. 1997. “Does central obesity reflect "Cushing’s disease of the omentum"?” Lancet (London, England) 349 (9060): 1210–13. https://doi.org/10.1016/S0140-6736(96)11222-8.
Cancello, R., J. Tordjman, C. Poitou, et al. 2006. “Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.” Diabetes 55 (6): 1554–61. https://doi.org/10.2337/db06-0133.
Chaston, T. B., and J. B. Dixon. 2008. “Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review.” International Journal of Obesity (2005) 32 (4): 619–28. https://doi.org/10.1038/sj.ijo.0803761.
Chau, Y. Y., R. Bandiera, A. Serrels, et al. 2014. “Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source.” Nature Cell Biology 16 (4): 367–75. https://doi.org/10.1038/ncb2922.
Cinti, S. 2005. “The adipose organ.” Prostaglandins, Leukotrienes, and Essential Fatty Acids 73 (1): 9–15. https://doi.org/10.1016/j.plefa.2005.04.010.
Cinti, S., G. Mitchell, G. Barbatelli, et al. 2005. “Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.” Journal of Lipid Research 46 (11): 2347–55. https://doi.org/10.1194/jlr.M500294-JLR200.
Cypess, A. M., S. Lehman, G. Williams, et al. 2009. “Identification and importance of brown adipose tissue in adult humans.” The New England Journal of Medicine 360 (15): 1509–17. https://doi.org/10.1056/NEJMoa0810780.
Eriksson-Hogling, D., D. P. Andersson, J. Bäckdahl, et al. 2015. “Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss.” International Journal of Obesity (2005) 39 (6): 893–98. https://doi.org/10.1038/ijo.2015.18.
Examination Committee of Criteria for ’Obesity Disease’ in Japan, and Japan Society for the Study of Obesity. 2002. “New criteria for ’obesity disease’ in Japan.” Circulation Journal : Official Journal of the Japanese Circulation Society 66 (11): 987–92. https://doi.org/10.1253/circj.66.987.
Fried, S. K., D. A. Bunkin, and A. S. Greenberg. 1998. “Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.” The Journal of Clinical Endocrinology and Metabolism 83 (3): 847–50. https://doi.org/10.1210/jcem.83.3.4660.
Friedman, J. M., and J. L. Halaas. 1998. “Leptin and the regulation of body weight in mammals.” Nature 395 (6704): 763–70. https://doi.org/10.1038/27376.
Garg, A. 2004. “Acquired and inherited lipodystrophies.” The New England Journal of Medicine 350 (12): 1220–34. https://doi.org/10.1056/NEJMra025261.
Gesta, S., M. Blüher, Y. Yamamoto, et al. 2006. “Evidence for a role of developmental genes in the origin of obesity and body fat distribution.” Proceedings of the National Academy of Sciences of the United States of America 103 (17): 6676–81. https://doi.org/10.1073/pnas.0601752103.
Hall, K. D. 2008. “What is the required energy deficit per unit weight loss?” International Journal of Obesity (2005) 32 (3): 573–76. https://doi.org/10.1038/sj.ijo.0803720.
Hoffstedt, J., E. Arner, H. Wahrenberg, et al. 2010. “Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity.” Diabetologia 53 (12): 2496–503. https://doi.org/10.1007/s00125-010-1889-3.
Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993. “Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.” Science (New York, N.Y.) 259 (5091): 87–91. https://doi.org/10.1126/science.7678183.
Ibrahim, M. M. 2010. “Subcutaneous and visceral adipose tissue: structural and functional differences.” Obesity Reviews : An Official Journal of the International Association for the Study of Obesity 11 (1): 11–18. https://doi.org/10.1111/j.1467-789X.2009.00623.x.
Kelley, D. E., F. L. Thaete, F. Troost, T. Huwe, and B. H. Goodpaster. 2000. “Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance.” American Journal of Physiology. Endocrinology and Metabolism 278 (5): E941–8. https://doi.org/10.1152/ajpendo.2000.278.5.E941.
Knittle, J. L., K. Timmers, F. Ginsberg-Fellner, R. E. Brown, and D. P. Katz. 1979. “The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size.” The Journal of Clinical Investigation 63 (2): 239–46. https://doi.org/10.1172/JCI109295.
Kuk, J. L., T. J. Saunders, L. E. Davidson, and R. Ross. 2009. “Age-related changes in total and regional fat distribution.” Ageing Research Reviews 8 (4): 339–48. https://doi.org/10.1016/j.arr.2009.06.001.
Lee, M. J., Y. Wu, and S. K. Fried. 2013. “Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.” Molecular Aspects of Medicine 34 (1): 1–11. https://doi.org/10.1016/j.mam.2012.10.001.
Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).” The Journal of Biological Chemistry 270 (22): 12953–56. https://doi.org/10.1074/jbc.270.22.12953.
Loke, Y. K., S. Singh, and C. D. Furberg. 2009. “Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.” CMAJ : Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne 180 (1): 32–39. https://doi.org/10.1503/cmaj.080486.
Lovejoy, J. C., C. M. Champagne, L. de Jonge, H. Xie, and S. R. Smith. 2008. “Increased visceral fat and decreased energy expenditure during the menopausal transition.” International Journal of Obesity (2005) 32 (6): 949–58. https://doi.org/10.1038/ijo.2008.25.
Maeda, K., K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara. 1996. “cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).” Biochemical and Biophysical Research Communications 221 (2): 286–89. https://doi.org/10.1006/bbrc.1996.0587.
Manolopoulos, K. N., F. Karpe, and K. N. Frayn. 2010. “Gluteofemoral body fat as a determinant of metabolic health.” International Journal of Obesity (2005) 34 (6): 949–59. https://doi.org/10.1038/ijo.2009.286.
Mehlem, A., C. E. Hagberg, L. Muhl, U. Eriksson, and A. Falkevall. 2013. “Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease.” Nature Protocols 8 (6): 1149–54. https://doi.org/10.1038/nprot.2013.055.
Meza-Perez, S., and T. D. Randall. 2017. “Immunological Functions of the Omentum.” Trends in Immunology 38 (7): 526–36. https://doi.org/10.1016/j.it.2017.03.002.
Miyazaki, Y., A. Mahankali, M. Matsuda, et al. 2002. “Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.” The Journal of Clinical Endocrinology and Metabolism 87 (6): 2784–91. https://doi.org/10.1210/jcem.87.6.8567.
Nesto, R. W., D. Bell, R. O. Bonow, et al. 2003. “Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.” Circulation 108 (23): 2941–48. https://doi.org/10.1161/01.CIR.0000103683.99399.7E.
Nielsen, S., Z. Guo, C. M. Johnson, D. D. Hensrud, and M. D. Jensen. 2004. “Splanchnic lipolysis in human obesity.” The Journal of Clinical Investigation 113 (11): 1582–88. https://doi.org/10.1172/JCI21047.
Oral, E. A., V. Simha, E. Ruiz, et al. 2002. “Leptin-replacement therapy for lipodystrophy.” The New England Journal of Medicine 346 (8): 570–78. https://doi.org/10.1056/NEJMoa012437.
Ouchi, N., S. Kihara, Y. Arita, et al. 1999. “Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.” Circulation 100 (25): 2473–76. https://doi.org/10.1161/01.cir.100.25.2473.
Pawlina, W., and M. H. Ross. 2020. Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. 8th ed. Wolters Kluwer.
Rosen, E. D., and B. M. Spiegelman. 2014. “What we talk about when we talk about fat.” Cell 156 (1-2): 20–44. https://doi.org/10.1016/j.cell.2013.12.012.
Ryo, M., T. Nakamura, S. Kihara, et al. 2004. “Adiponectin as a biomarker of the metabolic syndrome.” Circulation Journal : Official Journal of the Japanese Circulation Society 68 (11): 975–81. https://doi.org/10.1253/circj.68.975.
Scherer, P. E., S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish. 1995. “A novel serum protein similar to C1q, produced exclusively in adipocytes.” The Journal of Biological Chemistry 270 (45): 26746–49. https://doi.org/10.1074/jbc.270.45.26746.
Shimomura, I., T. Funahashi, M. Takahashi, et al. 1996. “Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity.” Nature Medicine 2 (7): 800–803. https://doi.org/10.1038/nm0796-800.
Spalding, K. L., E. Arner, P. O. Westermark, et al. 2008. “Dynamics of fat cell turnover in humans.” Nature 453 (7196): 783–87. https://doi.org/10.1038/nature06902.
Stenkula, K. G., and C. Erlanson-Albertsson. 2018. “Adipose cell size: importance in health and disease.” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 315 (2): R284–95. https://doi.org/10.1152/ajpregu.00257.2017.
Sun, K., C. M. Kusminski, and P. E. Scherer. 2011. “Adipose tissue remodeling and obesity.” The Journal of Clinical Investigation 121 (6): 2094–101. https://doi.org/10.1172/JCI45887.
Tchkonia, T., D. E. Morbeck, T. Von Zglinicki, et al. 2010. “Fat tissue, aging, and cellular senescence.” Aging Cell 9 (5): 667–84. https://doi.org/10.1111/j.1474-9726.2010.00608.x.
Tchkonia, T., Y. D. Tchoukalova, N. Giorgadze, et al. 2005. “Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots.” American Journal of Physiology. Endocrinology and Metabolism 288 (1): E267–77. https://doi.org/10.1152/ajpendo.00265.2004.
Tchkonia, T., T. Thomou, Y. Zhu, et al. 2013. “Mechanisms and metabolic implications of regional differences among fat depots.” Cell Metabolism 17 (5): 644–56. https://doi.org/10.1016/j.cmet.2013.03.008.
Van Harmelen, V., S. Reynisdottir, P. Eriksson, et al. 1998. “Leptin secretion from subcutaneous and visceral adipose tissue in women.” Diabetes 47 (6): 913–17. https://doi.org/10.2337/diabetes.47.6.913.
Virtue, S., and A. Vidal-Puig. 2010. “Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome–an allostatic perspective.” Biochimica Et Biophysica Acta 1801 (3): 338–49. https://doi.org/10.1016/j.bbalip.2009.12.006.
Wajchenberg, B. L. 2000. “Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.” Endocrine Reviews 21 (6): 697–738. https://doi.org/10.1210/edrv.21.6.0415.
Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and Ferrante AW Jr. 2003. “Obesity is associated with macrophage accumulation in adipose tissue.” The Journal of Clinical Investigation 112 (12): 1796–808. https://doi.org/10.1172/JCI19246.
Weyer, C., J. E. Foley, C. Bogardus, P. A. Tataranni, and R. E. Pratley. 2000. “Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.” Diabetologia 43 (12): 1498–506. https://doi.org/10.1007/s001250051560.
WHO Expert Consultation. 2004. “Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.” Lancet (London, England) 363 (9403): 157–63. https://doi.org/10.1016/S0140-6736(03)15268-3.
Wu, J., P. Boström, L. M. Sparks, et al. 2012. “Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human.” Cell 150 (2): 366–76. https://doi.org/10.1016/j.cell.2012.05.016.
Yamauchi, T., J. Kamon, H. Waki, et al. 2001. “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.” Nature Medicine 7 (8): 941–46. https://doi.org/10.1038/90984.
菅波孝祥. 2024. “加齢による皮下脂肪萎縮の分子基盤の解明.” コスメトロジー研究報告(コーセーコスメトロジー研究財団) 32: 109–13. https://www.kose-cosmetology.or.jp/research_report/archives/2024/fullVersion/Cosmetology_Vol32_2024_p109-113_Takayoshi_Suganuma.pdf.

日本語で読める関連資料(本文では引用していないもの)

以下は内容の入門・補足として読める日本語の資料です。本資料の作成時に本文を確認できなかったため、本文の主張の出典としては使っていません。